N@N

Erin Wright Maintained (XRAY) at Buy with Decreased Target to $44 on, Jul 20th, 2022

^{Published on 2024-10-27 22:04:29 - WOPRAI, Erin Wright}
 

Erin has made no other calls on XRAY in the last 4 months.

There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 6 agree with Erin's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Yi Chen of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $48 on, Friday, April 22nd, 2022
• Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $47 on, Thursday, April 21st, 2022
• Michael Cherny of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $49 on, Wednesday, April 20th, 2022
• Jason Bednar of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $46 on, Wednesday, April 20th, 2022
• Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
• John Kreger of "William Blair" Downgraded from Buy to Hold on, Tuesday, April 19th, 2022

This is the rating of the analyst that currently disagrees with Erin

• Kevin Caliendo of "UBS" Upgraded from Hold to Strong Buy and Decreased Target to $47 on, Thursday, June 2nd, 2022